Journal Article

Improving access to appropriate post-exposure doxycycline for Lyme disease prophylaxis: role for community pharmacies

Allison M Dering-Anderson and Alex J Adams

in Journal of Antimicrobial Chemotherapy

Published on behalf of British Society for Antimicrobial Chemotherapy

Volume 73, issue 12 Published in print December 2018 | ISSN: 0305-7453
Published online September 2018 | e-ISSN: 1460-2091 | DOI: https://dx.doi.org/10.1093/jac/dky361
Improving access to appropriate post-exposure doxycycline for Lyme disease prophylaxis: role for community pharmacies

More Like This

Show all results sharing these subjects:

  • Medical Oncology
  • Critical Care

GO

Show Summary Details

Preview

Abstract

The transmission of Borrelia burgdorferi to humans through tick bites results in Lyme disease. Appropriate therapy for Lyme disease is antibacterial drugs, most often doxycycline. Patients often approach community pharmacists for self-care assistance with the symptoms of Lyme disease: fever, headache, fatigue and skin rash. Pharmacists with the patient history are trained and capable of appropriately dispensing doxycycline to treat these patients and prevent the spread of infection to the joints, nerves or heart. We challenge restrictions to the appropriate and timely provision of therapy for Lyme disease and encourage the use of community pharmacists in managing these patients.

Journal Article.  1293 words. 

Subjects: Medical Oncology ; Critical Care

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or purchase to access all content.